Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Lyell Immunopharma, Inc. - Common Stock
(NQ:
LYEL
)
0.4280
+0.0070 (+1.66%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 8, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lyell Immunopharma, Inc. - Common Stock
< Previous
1
2
3
4
Next >
Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2023
May 04, 2023
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Lyell Immunopharma to Participate in BofA Securities Healthcare Conference
May 02, 2023
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 22, 2023
Via
Benzinga
Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2022
February 28, 2023
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
GSK Walks Away From T-Cell Therapy Pact With Lyell Citing Strategic Actions
October 25, 2022
Via
Benzinga
Analyst Sees A Leader In Solid Tumor Cell Therapy In This Stock
October 17, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
February 14, 2023
During Tuesday, 40 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
February 13, 2023
On Monday, 42 companies hit new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 18, 2023
Via
Benzinga
Lyell Immunopharma to Participate in 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Lyell Immunopharma Appoints Lynn Seely, MD as President and Chief Executive Officer
December 15, 2022
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Lululemon, Li Auto, Hackett Group And Some Other Big Stocks Moving Lower On Friday
December 09, 2022
U.S. stocks traded lower, with the Dow Jones jumping around 70 points on Friday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Lyell Immunopharma to Participate in BofA Securities Biotech Conference
December 01, 2022
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Lyell Immunopharma to Participate in Barclays Virtual Fireside Chat Series
November 10, 2022
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Lyell Immunopharma Reports Recent Business Highlights and Third Quarter Financial Results
November 08, 2022
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday
November 10, 2022
Gainers
Via
Benzinga
Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session
November 09, 2022
Gainers
Via
Benzinga
Lyell Immunopharma Presents New Data at SITC Highlighting its Growing Pipeline of T – Cell Reprogramming Technologies and Product Candidates Targeting Solid Tumors
November 07, 2022
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Lyell Immunopharma to Participate in Credit Suisse Healthcare Conference
November 02, 2022
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 25, 2022
Gainers
Via
Benzinga
5 Value Stocks In The Healthcare Sector
October 17, 2022
What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2022
October 17, 2022
Upgrades
Via
Benzinga
Lyell Immunopharma Announces FDA Clearance of its IND for LYL845, a TIL Product Candidate Enhanced with its Novel Epigenetic Reprogramming Technology for Solid Tumors
October 06, 2022
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Lyell Immunopharma to Present Preclinical Data Highlighting New T-Cell Reprogramming Technologies and its Growing Pipeline at 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting
October 05, 2022
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Lyell Immunopharma Announces the Appointment of Rahsaan Thompson as Chief Legal Officer
September 28, 2022
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
5 Value Stocks In The Healthcare Sector
September 12, 2022
What are Value Stocks?
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
August 26, 2022
Via
Benzinga
Why U.S. Stocks Are Trading Lower; AZZ Earnings And More
July 11, 2022
U.S. stocks traded lower this morning as investors digested the recent jobs report for the month of June.
Via
Benzinga
Biotech ETF Tops in June: 5 Stocks That Outperform
June 30, 2022
Although most of the stocks in BBC’s portfolio have delivered strong returns this year so far, a few have gained more than 45%.
Via
Talk Markets
89 Biggest Movers From Friday
June 21, 2022
Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy.
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.